Back

Corvus Pharmaceuticals, Inc.

CRVS — Neutre
Scan this asset

Last analysis : 2026-05-07 · US · 50 views

Corvus Pharmaceuticals, Inc.
Key levels
Price 13.93
7% of S→R range
Sup. 13.510 Res. 19.700
MM50 13.33 ✓
MM200 13.06 ✓
52w 4.05 → 26.95 (-48.3%)
ATR(14) 0.7107 (5.1%/j)
Create a free account →